Abstract
The human gut microbiota has been identified as a possible novel risk factor for cardiovascular disease. The intestinal microbiome plays a role in the pathogenesis of atherosclerosis and heart failure. Even though studies in rodents suggested that gut microbes may affect the risk of heart disease, this link has not been shown in humans. In the present study, we review several potential mechanisms by which the gut microbiome and bacterial translocation are associated with the development of cardiac disorders making them potential targets for novel therapeutic measures for these conditions. Modulation of the gut microbiota as a mechanism for altering the pathogenesis of disorders is an area of growing interest. Alteration in the gut microbiota is being explored as a method of reducing risk factors associated with cardiac diseases.
Subject
Cardiology and Cardiovascular Medicine
Reference66 articles.
1. Gut microbiota metabolism of l-carnitine and cardiovascular risk
2. Gut microbes may affect heart disease risk. but studies in rodents suggesting a link may not play out in people. Harv Heart Lett 2012;22.
3. Inflammation and metabolic disorders
4. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
5. Cox AJ , West NP , Cripps AW . Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol, 2014.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献